Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin Pradere

Showing results (281-290 of 412) with videos related to

Pageof 42
Sort By:
The Oncologist|July 3, 2024
Cisplatin eligibility in the neoadjuvant setting of patients with muscle-invasive bladder cancer undergoing radical cystectomyRenate Pichler, Josef Fritz, Andrea Mari, et al.
World Journal of Urology|May 25, 2020
Correction to: COVID-19 outbreak situation and its psychological impact among surgeons in training in FranceMaher Abdessater, Morgan Rouprêt, Vincent Misrai, et al.
The Lancet. Oncology|August 30, 2025
TAR-200 plus cetrelimab versus cetrelimab monotherapy as neoadjuvant therapy in patients with muscle-invasive bladder cancer who are ineligible for or decline neoadjuvant cisplatin-based chemotherapy (SunRISe-4): interim analysis of a randomised, open-label phase 2 trialAndrea Necchi, Félix Guerrero-Ramos, Paul L Crispen, et al.
World Journal of Urology|April 26, 2020
COVID-19 outbreak situation and its psychological impact among surgeons in training in FranceMaher Abdessater, Morgan Rouprêt, Vincent Misrai, et al.
Urologic Oncology|November 23, 2021
Impact of preoperative systemic immune-inflammation Index on oncologic outcomes in bladder cancer patients treated with radical cystectomyNico C Grossmann, Victor M Schuettfort, Benjamin Pradere, et al.
Journal of Personalized Medicine|November 27, 2021
Evaluation of the Predictive Role of Blood-Based Biomarkers in the Context of Suspicious Prostate MRI in Patients Undergoing Prostate BiopsyPawel Rajwa, Nicolai A Huebner, Dadjar I Hostermann, et al.
Minerva Urology and Nephrology|June 26, 2024
Application of the ERAS guidelines in pediatric urological surgery: a systematic reviewJudith Stangl-Kremser, Laura Olivera, Sofia Giudici, et al.
World Journal of Urology|June 9, 2023
Clinical value of cholinesterase in patients treated with radical nephroureterectomy for upper urinary tract carcinomaMarkus von Deimling, David D'Andrea, Benjamin Pradere, et al.
BJU International|March 2, 2021
A panel of systemic inflammatory response biomarkers for outcome prediction in patients treated with radical cystectomy for urothelial carcinomaVictor M Schuettfort, David D'Andrea, Fahad Quhal, et al.
BJU International|July 3, 2025
The role of primary tumour site surgery in metastatic UTUC: a systematic review and meta-analysisLudovica Cella, Stefano Moretto, Roberto Contieri, et al.
Pageof 42

Showing results (281-290 of 412) with videos related to

Sort By:
Pageof 42
The Oncologist|July 3, 2024
Cisplatin eligibility in the neoadjuvant setting of patients with muscle-invasive bladder cancer undergoing radical cystectomyRenate Pichler, Josef Fritz, Andrea Mari, et al.
World Journal of Urology|May 25, 2020
Correction to: COVID-19 outbreak situation and its psychological impact among surgeons in training in FranceMaher Abdessater, Morgan Rouprêt, Vincent Misrai, et al.
The Lancet. Oncology|August 30, 2025
TAR-200 plus cetrelimab versus cetrelimab monotherapy as neoadjuvant therapy in patients with muscle-invasive bladder cancer who are ineligible for or decline neoadjuvant cisplatin-based chemotherapy (SunRISe-4): interim analysis of a randomised, open-label phase 2 trialAndrea Necchi, Félix Guerrero-Ramos, Paul L Crispen, et al.
World Journal of Urology|April 26, 2020
COVID-19 outbreak situation and its psychological impact among surgeons in training in FranceMaher Abdessater, Morgan Rouprêt, Vincent Misrai, et al.
Urologic Oncology|November 23, 2021
Impact of preoperative systemic immune-inflammation Index on oncologic outcomes in bladder cancer patients treated with radical cystectomyNico C Grossmann, Victor M Schuettfort, Benjamin Pradere, et al.
Journal of Personalized Medicine|November 27, 2021
Evaluation of the Predictive Role of Blood-Based Biomarkers in the Context of Suspicious Prostate MRI in Patients Undergoing Prostate BiopsyPawel Rajwa, Nicolai A Huebner, Dadjar I Hostermann, et al.
Minerva Urology and Nephrology|June 26, 2024
Application of the ERAS guidelines in pediatric urological surgery: a systematic reviewJudith Stangl-Kremser, Laura Olivera, Sofia Giudici, et al.
World Journal of Urology|June 9, 2023
Clinical value of cholinesterase in patients treated with radical nephroureterectomy for upper urinary tract carcinomaMarkus von Deimling, David D'Andrea, Benjamin Pradere, et al.
BJU International|March 2, 2021
A panel of systemic inflammatory response biomarkers for outcome prediction in patients treated with radical cystectomy for urothelial carcinomaVictor M Schuettfort, David D'Andrea, Fahad Quhal, et al.
BJU International|July 3, 2025
The role of primary tumour site surgery in metastatic UTUC: a systematic review and meta-analysisLudovica Cella, Stefano Moretto, Roberto Contieri, et al.
Pageof 42